Lung Cancer Screening
special focus
lung cancer screening
20-21, January, 2025
online
What to expect
During this two-day online course, you will learn about a variety of topics in lung cancer screening.
Day one will cover everything from trends, technical requirements and test trials to the details of solid and subsolid nodules, as well as concrete cases from cancer screening programmes.
Day two will build your knowledge about current guidelines, how to report on incidental findings, AI in cancer screening and much more!
The best thing is, this course is available for free to all radiologists and radiographers.
Renowned European experts ensure a high quality-teaching programme
combining theory and case presentations with an interactive character.
hosts & venue
Mike Walt, MA
Leadership, Team Effectiveness & Communications Coach
Venue will be announced soon!
- BA in Communications | MA in Organizational Leadership
- Certified 6 Team Conditions Coach & Team Diagnostic Survey Administrator
- Certified Neethling Brain Instrument (NBI) Coach
- Certified Lead, Develop, Care (LDC) Coach
Assoc. Prof. Dr Helmut Prosch
Section Chief of Thoracic Imaging at Medical University of Vienna
Venue will be announced soon!
- Experienced lecturer and educator with over 1500 talks delivered in more than 40 coutries
VENUE
Medical University of Vienna
Radiology Center
Lazarettgasse 25
1090 Wien
Accreditation
Applications will be made to the European Accreditation Council for Continuing Medical Education (EACCME) for CME accreditation of this event.
The ESOR Visiting Professorship to Ukraine has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 10.0 European CME credits (ECMEC®s)
Certificates with CME credits will be issued only after participating in the course activities and completing an online evaluation form.
Participation in both course days is a requirement to receive CME credits.
We work with impartiality and transparency. Find the steering committee disclosure forms here →
Learning Objectives
Day 1
- learn about the scientific evidence obtained from lung cancer screening trials
- gain knowledge of the epidemiology of lung cancer across different European countries
- develop skills in dose requirements and reading modalities
- gain confidence in the assessment of solid nodules
- learn to describe and manage sub-solid nodules effectively
Day 2
- learn how to adapt follow-up intervals based on CT scan results.
- understand the challenges associated with incidental findings.
- understand the risks of over-diagnosis and stage change.
- comprehend the performance and limitations of AI in lung cancer screening.
- learn about the current state of lung cancer screening in Europe.
- explore the biomarker candidates currently under study in lung cancer screening.
course structure
Small group for the big impact
This course is limited to 16 participants to ensure low instructor-trainee ratio
Pre-course online meeting
An online video call will allow to get to know eachother, set the expectations for the course and assign pre-course tasks for participants
Hands-on training in Vienna
You will meet in-person for a two-day intensive training with interactive tasks, constrictive feedback and self-reflection activities
Post-programme follow-up call
One-month after the course in Vienna you will have a follow-up video call with instructors
Programme
*all times given in local time in Astana
| 12:30 – 13:10 | Lung cancer screening trials: acquired evidence and remaining questions Cornelia Schaefer-Prokop, Amersfoort/NL |
| 13:10 – 13:50 | Epidemiology of lung cancer in European countries: what are the trends H. Zahed, Lyon/FR |
| 13:50 – 14:30 | How to conduct lung cancer screening: technical requirements and quality assurance Marie-pierre Revel Paris/FR |
| 14:30 – 15:00 | Q&A session |
| 15:00 – 15:30 | Break |
| 15:30 – 16:10 | Solid nodules: morphological evaluation, criteria for growth during follow-up Helmut Prosch, Vienna/AT |
| 16:10 – 16:50 | Subsolid nodules: morphological evaluation, criteria for growth during follow-up Mario Silva, Parma/IT |
| 16:50 – 17:30 | Case-Based Session Jens Vogel-Claussen, Hannover/DE |
| 17:30 – 18:00 | Q&A Session |
*all times given in local time in Astana
| 12:30 – 13:10 | ESTI guidelines : definition of positive negative and indeterminate results, follow-up intervals Mathias Prokop, Nijmegen/NL |
| 13:10 – 13:50 | Incidental findings: what could be and what should be reported Annemiek Snoeckx, Antwerp/BE |
| 13:50 – 14:30 | Role of AI in lung cancer screening Fergus Gleeson, Oxford/UK |
| 14:30 – 15:00 | Q&A session |
| 15:00 – 15:30 | Break |
| 15:30 – 16:10 | An overview of ongoing programs in Europe, the SOLACE project Hans Ulrich Kauczor, Heidelberg /DE |
| 16:10 – 16:50 | Is there a role for biomarkers? Joanna Chorostowska Varsaw/PO |
| 16:50 – 17:30 | Case-Based Session Anna Kerpel-Fronius, Budapest/HU |
| 17:30 – 18:00 | Q&A Session |
Fees
free of charge
For all radiologists, radiologists-in-training and radiographers, incl. those who are not yet members of the ESR.
the world of radiology is yours
Apply now for a chance to go on one of our many one- or two-year fellowship around the world!
